Business ❯ Finance

Analyst Expectations

Earnings Estimates Revenue Forecasts Earnings Reports Earnings Guidance Earnings Per Share Earnings Forecasts Earnings Forecast Revenue Projections Forecasting Market Analysis Wall Street Analysts Quarterly Earnings Profit Forecasts Earnings Expectations Financial Forecasts Stock Ratings Sales Forecast Market Predictions Quarterly Reports Market Forecasts Earnings Projections Sales Performance Revenue Analysis Revenue Forecasting Zacks Investment Research FactSet Revenue Growth Revenue Estimates Stock Valuation Earnings Surprises Stock Performance

Williams‑Sonoma Raises Full‑Year Outlook After Tariff Refunds Boost Q2 Results

Cash refunds raised GAAP profit as management excludes the income from non‑GAAP measures to highlight core sales and margin trends.

Pinterest Beats Q2 Estimates but Signals Slower Revenue Growth

Humana Cuts GAAP Profit Outlook After Drop in Medicare Star Ratings

GE Aerospace Beats Q2 Estimates, Raises 2026 Guidance as Stock Dips

Progressive Posts Strong Premium and Policy Growth but June Profit Falls

Semtech Shares Surge After Strong Q1 Results and Bullish Q2 Guidance

Booz Allen Tops Profit Estimates but Misses Revenue as Investors Eye Dividend

CoreWeave Stock Falls After Soft Q2 Outlook Misses Wall Street Targets

Rackspace Soars After Revenue Beat and AMD AI Cloud MOU

Appian Tops Q1, Lifts 2026 Outlook on AI-Fueled Subscription Gains

PTC Beats Q2 Estimates, Lifts Full-Year Revenue Guidance

Eaton Shares Fall After Record Q1 as Guidance Disappoints

WEC Energy Tops Q1 Forecasts, Reaffirms 2026 Outlook

S&P Global Posts Q1 Beat, Boosts Capital Return Plan and Reaffirms 2026 Outlook

Maersk Swings to Q4 Loss, Cuts 1,000 Jobs and Launches $1 Billion Buyback

Royal Caribbean Raises 2026 Outlook as Record Bookings and New Beach Clubs Fuel Re‑Rating

Commvault Shares Plunge 31% After Q3 as Outlook Disappoints

Beyond Meat Posts Wider Q3 Loss, Books $77.4 Million Impairment and Guides to Weaker Q4

Haemonetics Beats Q3 Targets, Lifts EPS Outlook as Shares Surge

Teva Tops Q3 Views, Lifts Austedo Outlook as It Narrows Full-Year Sales Range